Nasdaq Halts CNS Pharmaceuticals Inc.

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market^® NDAQ announced that the trading halt status in CNS Pharmaceuticals Inc. CNSP was changed to "additional information requested" from the company. Trading in the company's stock had been halted on May 4, 2020 at 9:25:06 Eastern Time  at a last sale price of $2.76.

Trading will remain halted until CNS Pharmaceuticals Inc. has fully satisfied Nasdaq's request for additional information.

For news and additional information about the company, please contact the company directly or check under the company's symbol using InfoQuotes^SM on the Nasdaq^® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:

Bianca Fata

Bianca.Fata@nasdaq.com